KPIs & Operating Metrics(New)
Growth Metrics

Stryker (SYK) Cash & Equivalents (2016 - 2025)

Stryker (SYK) has disclosed Cash & Equivalents for 17 consecutive years, with $4.0 billion as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 9.83% to $4.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 billion through Dec 2025, up 9.83% year-over-year, with the annual reading at $4.0 billion for FY2025, 9.83% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $4.0 billion at Stryker, up from $3.3 billion in the prior quarter.
  • The five-year high for Cash & Equivalents was $4.0 billion in Q4 2025, with the low at $1.0 billion in Q2 2022.
  • Average Cash & Equivalents over 5 years is $2.4 billion, with a median of $2.3 billion recorded in 2021.
  • The sharpest move saw Cash & Equivalents crashed 65.73% in 2021, then soared 106.99% in 2024.
  • Over 5 years, Cash & Equivalents stood at $2.9 billion in 2021, then plummeted by 37.36% to $1.8 billion in 2022, then surged by 61.12% to $3.0 billion in 2023, then increased by 22.92% to $3.7 billion in 2024, then grew by 9.83% to $4.0 billion in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $4.0 billion, $3.3 billion, and $2.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.